サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1472125

医療用外骨格の世界市場規模調査＆予測、タイプ別、モビリティ別、コンポーネント別、用途別、地域別分析、2023年～2030年

Global Medical Exoskeleton Market Size Study & Forecast, by Type, by Mobility, by Component, by Application and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=142.54円
医療用外骨格の世界市場規模調査＆予測、タイプ別、モビリティ別、コンポーネント別、用途別、地域別分析、2023年～2030年
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療用外骨格市場は、2022年におよそ3億米ドルと評価され、予測期間2023-2030年には29.40％以上の健全な成長率で成長すると予測されています。

医療用外骨格は、装着者の身体能力を補助、強化、リハビリするために設計された装着型ロボット装置です。これらのデバイスは、一般的に医療現場で、運動障害、神経障害、筋骨格系損傷のある人を支援するために使用されます。また、医療用外骨格は、麻痺や運動障害のある人が立ち上がり、歩行し、日常活動を行うのを助ける。医療用外骨格は、使用者の手足をサポートし、筋力と協調性を増強します。さらに、神経疾患の有病率の増加、脊髄損傷や脳損傷の数の増加、老人人口の増加、外骨格技術の開発のための企業や研究機関の間の合意や共同開発の増加は、予測期間2023-2030の間に市場の有利な需要を創出すると予想されます。

脳卒中、脊髄損傷、多発性硬化症、パーキンソン病などの神経疾患は、移動や自立を著しく制限する可能性があります。医療用外骨格は、そのような状態にある人々に支援とサポートを提供することで解決策を提供し、彼らが運動能力を取り戻し、自立して日常活動を行うことを可能にします。パーキンソン財団によると、世界中で1,000万人以上がパーキンソン病（PD）に苦しんでおり、毎年6万人のアメリカ人がパーキンソン病と診断されています。また、世界保健機関（WHO）によると、神経疾患は世界の疾病負担の6.3％を占めています。このため、革新的で効果的な治療法に対する需要が増加しており、これが医療用外骨格の成長を牽引しています。さらに、市場プレーヤーによる製品承認数の増加、医療費の増加は、市場に有利な機会を創出すると予測されています。しかし、医療用外骨格の承認を確保するための規制上の課題、および高い機器コストが、2023-2030年の予測期間を通じて市場成長を阻害しています。

医療用外骨格の世界市場調査で考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は、ロボット工学、材料科学、人工知能の急速な進歩、支持的な規制環境、主要市場プレイヤーの存在により、2022年の市場を独占しました。一方、アジア太平洋地域は、神経疾患の罹患率の上昇、高齢化人口の増加、政府のまとまったイニシアチブと資金提供などの要因により、予測期間中に最も速い成長率で成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の医療用外骨格市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 医療用外骨格の世界市場力学

  • 医療用外骨格市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 神経疾患の有病率の増加
      • 脊髄損傷と脳損傷の増加
      • 老人人口の増加
    • 市場の課題
      • 医療用外骨格の承認確保のための規制上の課題
      • 高い機器コスト
    • 市場機会
      • 市場参入企業による製品承認の増加
      • ヘルスケア支出の増加

第4章 世界の医療用外骨格市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 医療用外骨格の世界市場：タイプ別

  • 市場スナップショット
  • 医療用外骨格の世界市場：タイプ別、実績 - ポテンシャル分析
  • 医療用外骨格の世界市場：タイプ別推定・予測、2020年～2030年
  • 医療用外骨格の世界市場、サブセグメント別分析
    • 動力式外骨格
    • パッシブ外骨格

第6章 医療用外骨格の世界市場、モビリティ別

  • 市場スナップショット
  • 医療用外骨格の世界市場：モビリティ別、実績 - ポテンシャル分析
  • 医療用外骨格の世界市場：モビリティ別推定・予測、2020年～2030年
  • 医療用外骨格の世界市場、サブセグメント別分析
    • 定置型
    • 移動式

第7章 医療用外骨格の世界市場：コンポーネント別

  • 市場スナップショット
  • 医療用外骨格の世界市場：コンポーネント別、実績 - ポテンシャル分析
  • 医療用外骨格の世界市場、コンポーネント別推定・予測、2020年～2030年
  • 医療用外骨格の世界市場、サブセグメント別分析
    • ハードウェア
    • ソフトウェア

第8章 医療用外骨格の世界市場：用途別

  • 市場スナップショット
  • 医療用外骨格の世界市場：用途別、実績 - ポテンシャル分析
  • 医療用外骨格の世界市場、用途別推定・予測、2020年～2030年
  • 医療用外骨格市場、サブセグメント分析
    • 脊髄損傷
    • 脳卒中
    • その他

第9章 医療用外骨格の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 医療用外骨格の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020年～2030年
      • モビリティの推定・予測、2020年～2030年
      • コンポーネントの推定・予測、2020年～2030年
      • 用途の推定・予測、2020～2030年
    • カナダ
  • 欧州の医療用外骨格市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の医療用外骨格市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの医療用外骨格市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第10章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Ekso Bionics Holdings, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • ReWalk Robotics Ltd.
    • Parker-Hannifin Corporation
    • Cyberdyne, Inc.
    • Bionik Laboratories Corp.
    • Rex Bionics PLC
    • B-TEMIA Incorporated
    • Bioventus LLC
    • Hocoma AG（part of DIH Technologies AG）
    • Wearable Robotics SRL

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Medical Exoskeleton Market, report scope
  • TABLE 2.Global Medical Exoskeleton Market estimates & forecasts by region 2020-2030 (USD Billion)
  • TABLE 3.Global Medical Exoskeleton Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4.Global Medical Exoskeleton Market estimates & forecasts by Mobility 2020-2030 (USD Billion)
  • TABLE 5.Global Medical Exoskeleton Market estimates & forecasts by Component 2020-2030 (USD Billion)
  • TABLE 6.Global Medical Exoskeleton Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 7.Global Medical Exoskeleton Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Medical Exoskeleton Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Medical Exoskeleton Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Medical Exoskeleton Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Medical Exoskeleton Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Medical Exoskeleton Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Medical Exoskeleton Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Medical Exoskeleton Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Medical Exoskeleton Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.Global Medical Exoskeleton Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18.U.S. Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.U.S. Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20.Canada Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21.Canada Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.Canada Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23.UK Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24.UK Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.UK Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26.Germany Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27.Germany Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.Germany Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29.France Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30.France Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.France Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32.Italy Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33.Italy Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Italy Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35.Spain Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36.Spain Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.Spain Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38.RoE Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39.RoE Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.RoE Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41.China Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42.China Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.China Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44.India Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45.India Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.India Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47.Japan Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48.Japan Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.Japan Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50.South Korea Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51.South Korea Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.South Korea Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53.Australia Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54.Australia Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.Australia Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.RoAPAC Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59.Brazil Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60.Brazil Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Brazil Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62.Mexico Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63.Mexico Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.Mexico Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65.RoLA Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66.RoLA Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.RoLA Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68.Saudi Arabia Medical Exoskeleton Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69.South Africa Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70.RoMEA Medical Exoskeleton Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71.List of secondary sources, used in the study of global Medical Exoskeleton Market
  • TABLE 72.List of primary sources, used in the study of global Medical Exoskeleton Market
  • TABLE 73.Years considered for the study
  • TABLE 74.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Medical Exoskeleton Market, research methodology
  • FIG 2.Global Medical Exoskeleton Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Medical Exoskeleton Market, key trends 2022
  • FIG 5.Global Medical Exoskeleton Market, growth prospects 2023-2030
  • FIG 6.Global Medical Exoskeleton Market, porters 5 force model
  • FIG 7.Global Medical Exoskeleton Market, pest analysis
  • FIG 8.Global Medical Exoskeleton Market, value chain analysis
  • FIG 9.Global Medical Exoskeleton Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Medical Exoskeleton Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Medical Exoskeleton Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Medical Exoskeleton Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Medical Exoskeleton Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Medical Exoskeleton Market, regional snapshot 2020 & 2030
  • FIG 15.North America Medical Exoskeleton Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Medical Exoskeleton Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Medical Exoskeleton Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Medical Exoskeleton Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Medical Exoskeleton Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Medical Exoskeleton Market is valued at approximately USD 0.3 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 29.40% over the forecast period 2023-2030. Medical exoskeleton is a wearable robotic device designed to assist, enhance, or rehabilitate the physical abilities of its wearer. These devices are typically used in medical settings to aid individuals with mobility impairments, neurological disorders, or musculoskeletal injuries. Medical exoskeletons also help individuals with paralysis or mobility impairments to stand up, walk, and perform daily activities. They provide support to the user's limbs and augment their strength and coordination. Moreover, the increase in the prevalence of neurological disorders, rising the number of spinal cord injuries and brain injuries, the growing number of geriatric populations, and growing agreements and collaborations among companies and research organizations for the development of exoskeleton technology that anticipated to create the lucrative demand for the market during the forecast period 2023-2030.

Neurological disorders such as stroke, spinal cord injuries, multiple sclerosis, Parkinson's disease, and others can severely limit mobility and independence. Medical exoskeletons offer a solution by providing assistance and support to individuals with such conditions, enabling them to regain mobility and perform daily activities independently. According to the Parkinson's Foundation, more than 10 million people globally suffer from Parkinson's Disease (PD), and 60,000 Americans have been diagnosed with Parkinson's disease every year. Also, according to the World Health Organization, neurological disorders are responsible for 6.3% of the global disease burden. This has led to an increase in demand for innovative and effective treatments, which has driven the growth of the Medical Exoskeleton. Moreover, the rising number of product approvals by market players, and rising healthcare expenditure are anticipated to create a lucrative opportunity for the market. However, the regulatory challenges for securing approvals for medical exoskeletons, and high equipment cost stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Medical Exoskeleton Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rapid advancements in robotics, materials science, and artificial intelligence, supportive regulatory environment, and the presence of key market players. Whereas the Asia Pacific is expected to grow at the fastest growth rate during the forecast period, owing to factors such as the rising incidence of neurological disorders, increasing ageing population, and cohesive government initiatives and funding.

Major market players included in this report are:

  • Ekso Bionics Holdings, Inc.
  • ReWalk Robotics Ltd.
  • Parker-Hannifin Corporation
  • Cyberdyne, Inc.
  • Bionik Laboratories Corp.
  • Rex Bionics PLC
  • B-TEMIA Incorporated
  • Bioventus LLC
  • Hocoma AG (part of DIH Technologies AG)
  • Wearable Robotics SRL

Recent Developments in the Market:

  • In December 2022, Ekso Bionics, a prominent figure in exoskeleton technology for medical and industrial applications, revealed its acquisition of the Human Motion and Control ("HMC") Business Unit from Parker Hannifin Corporation, a renowned global leader in motion and control technologies. Through this acquisition accompany expand its market presence globally.

Global Medical Exoskeleton Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Mobility, Component, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Powered exoskeleton
  • Passive exoskeleton

By Mobility:

  • Stationary
  • Mobile

By Component:

  • Hardware
  • Software

By Application:

  • Spinal Cord Injury
  • Stroke
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Medical Exoskeleton Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Medical Exoskeleton Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3.Medical Exoskeleton Market, by Mobility, 2020-2030 (USD Billion)
    • 1.2.4.Medical Exoskeleton Market, by Component, 2020-2030 (USD Billion)
    • 1.2.5.Medical Exoskeleton Market, by Application, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Medical Exoskeleton Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Medical Exoskeleton Market Dynamics

  • 3.1.Medical Exoskeleton Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increase in the prevalence of neurological disorders
      • 3.1.1.2.Rising the number of spinal cord injuries and brain injuries
      • 3.1.1.3.Growing number of geriatric populations
    • 3.1.2.Market Challenges
      • 3.1.2.1.Regulatory challenges for securing approvals for medical exoskeletons
      • 3.1.2.2.High equipment cost
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Increasing number of product approvals by market players
      • 3.1.3.2.Rising healthcare expenditure

Chapter 4.Global Medical Exoskeleton Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Medical Exoskeleton Market, by Type

  • 5.1.Market Snapshot
  • 5.2.Global Medical Exoskeleton Market by Type, Performance - Potential Analysis
  • 5.3.Global Medical Exoskeleton Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4.Medical Exoskeleton Market, Sub Segment Analysis
    • 5.4.1. Powered exoskeleton
    • 5.4.2.Passive exoskeleton

Chapter 6.Global Medical Exoskeleton Market, by Mobility

  • 6.1.Market Snapshot
  • 6.2.Global Medical Exoskeleton Market by Mobility, Performance - Potential Analysis
  • 6.3.Global Medical Exoskeleton Market Estimates & Forecasts by Mobility 2020-2030 (USD Billion)
  • 6.4.Medical Exoskeleton Market, Sub Segment Analysis
    • 6.4.1. Stationary
    • 6.4.2.Mobile

Chapter 7.Global Medical Exoskeleton Market, by Component

  • 7.1.Market Snapshot
  • 7.2.Global Medical Exoskeleton Market by Component, Performance - Potential Analysis
  • 7.3.Global Medical Exoskeleton Market Estimates & Forecasts by Component 2020-2030 (USD Billion)
  • 7.4.Medical Exoskeleton Market, Sub Segment Analysis
    • 7.4.1. Hardware
    • 7.4.2.Software

Chapter 8.Global Medical Exoskeleton Market, by Application

  • 8.1.Market Snapshot
  • 8.2.Global Medical Exoskeleton Market by Application, Performance - Potential Analysis
  • 8.3.Global Medical Exoskeleton Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 8.4.Medical Exoskeleton Market, Sub Segment Analysis
    • 8.4.1. Spinal Cord Injury
    • 8.4.2.Stroke
    • 8.4.3.Others

Chapter 9.Global Medical Exoskeleton Market, Regional Analysis

  • 9.1.Top Leading Countries
  • 9.2.Top Emerging Countries
  • 9.3.Medical Exoskeleton Market, Regional Market Snapshot
  • 9.4.North America Medical Exoskeleton Market
    • 9.4.1.U.S. Medical Exoskeleton Market
      • 9.4.1.1.Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2.Mobility breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3.Component breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4.Application breakdown estimates & forecasts, 2020-2030
    • 9.4.2.Canada Medical Exoskeleton Market
  • 9.5.Europe Medical Exoskeleton Market Snapshot
    • 9.5.1.U.K. Medical Exoskeleton Market
    • 9.5.2.Germany Medical Exoskeleton Market
    • 9.5.3.France Medical Exoskeleton Market
    • 9.5.4.Spain Medical Exoskeleton Market
    • 9.5.5.Italy Medical Exoskeleton Market
    • 9.5.6.Rest of Europe Medical Exoskeleton Market
  • 9.6.Asia-Pacific Medical Exoskeleton Market Snapshot
    • 9.6.1.China Medical Exoskeleton Market
    • 9.6.2.India Medical Exoskeleton Market
    • 9.6.3.Japan Medical Exoskeleton Market
    • 9.6.4.Australia Medical Exoskeleton Market
    • 9.6.5.South Korea Medical Exoskeleton Market
    • 9.6.6.Rest of Asia Pacific Medical Exoskeleton Market
  • 9.7.Latin America Medical Exoskeleton Market Snapshot
    • 9.7.1.Brazil Medical Exoskeleton Market
    • 9.7.2.Mexico Medical Exoskeleton Market
  • 9.8.Middle East & Africa Medical Exoskeleton Market
    • 9.8.1.Saudi Arabia Medical Exoskeleton Market
    • 9.8.2.South Africa Medical Exoskeleton Market
    • 9.8.3.Rest of Middle East & Africa Medical Exoskeleton Market

Chapter 10.Competitive Intelligence

  • 10.1.Key Company SWOT Analysis
  • 10.2.Top Market Strategies
  • 10.3.Company Profiles
    • 10.3.1. Ekso Bionics Holdings, Inc.
      • 10.3.1.1.Key Information
      • 10.3.1.2.Overview
      • 10.3.1.3.Financial (Subject to Data Availability)
      • 10.3.1.4.Product Summary
      • 10.3.1.5.Recent Developments
    • 10.3.2.ReWalk Robotics Ltd.
    • 10.3.3.Parker-Hannifin Corporation
    • 10.3.4.Cyberdyne, Inc.
    • 10.3.5.Bionik Laboratories Corp.
    • 10.3.6.Rex Bionics PLC
    • 10.3.7.B-TEMIA Incorporated
    • 10.3.8.Bioventus LLC
    • 10.3.9.Hocoma AG (part of DIH Technologies AG)
    • 10.3.10.Wearable Robotics SRL

Chapter 11.Research Process

  • 11.1.Research Process
    • 11.1.1.Data Mining
    • 11.1.2.Analysis
    • 11.1.3.Market Estimation
    • 11.1.4.Validation
    • 11.1.5.Publishing
  • 11.2.Research Attributes
  • 11.3.Research Assumption